Last Updated: 17 Oct 2025

Assistance to Medical Device Clusters for Common Facilities (AMD-CF) Scheme

The AMD-CF Scheme (2023–24 to 2026–27), managed by SIDBI, promotes self-reliance in medical device manufacturing by funding common facilities and testing laboratories within medical device clusters.

Quick Facts

  • Purpose: Promotes self-reliance in manufacturing of medical devices.
  • Tenure: 2023-24 to 2026-27
  • Components: Assistance for Common Facilities and Assistance for Testing Facilities
  • Project Management Agency: SIDBI

Objectives 

  • Strengthen Medical Device clusters by providing financial assistance and to strengthen and establish more Testing Laboratories for Medical Devices.

Salient Features 

Two Components 

  • Assistance for Common Facilities: For Creating Common Infrastructure Facilities. 
    • Incentive
      • Limit of support will be 70% of the approved project cost or Rs. 20 cr., whichever is less.
      • For Himalayan and North East Region States, grant-in-aid would be Rs. 20 Crore per Cluster or 90% of the project cost, whichever is less.
    • Special Purpose Vehicle (SPV) to be formed by the Medical Devices manufacturing units in a cluster to execute the project.
      • There shall be a minimum of 5 Medical Device manufacturing units as members of SPV.
      • State Government can also promote a cluster.
    • Individual manufacturing unit cannot hold more than 40% in the SPV. Medical Devices enterprises shall hold at least 51% equity of the SPV.
  • Assistance for Testing Facilities: To strengthen availability of more Medical Device Testing Laboratories in order to boost manufacturing of quality medical devices.
    • Incentive
      • Limit of support will be 70% of the approved Testing Facilities project cost or Rs. 5 cr., whichever is less.
      • For Himalayan and North East Region States, grant-in-aid would be Rs. 5 Crore per Cluster or 90% of the project cost, whichever is less.
    • Any National or State level Government or Private institutions interested to establish or strengthen testing facilities for testing of Class A, B, C and D medical devices including in-vitro diagnostic medical devices under MDR, 2017 are eligible.
      • Such legal entity under the Indian law will open a separate account for the funds to be utilized for the projects assisted under the sub-scheme.
A diagram showing the National Medical Devices Policy 2023 divided into Vision and Strategy sections - Vision includes accelerated growth with patient-centric approach, emerging as global leader achieving 10-12% market share over 25 years, and growing the sector from $11 Bn to $50 Bn by 2030; Strategy includes Regulatory Streamlining, Enabling Infrastructure, Facilitating R&D and Innovation, Attracting Investments, Human Resources Development, and Brand Positioning and Awareness Creation.

 

Subscribe for Premium Features

Quick Start

Use our Quick Start guide to learn about everything this platform can do for you.
Get Started